Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seerapani Gopaluni

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Current Treatment Options in Rheumatology|September 23, 2017
Clinical Trials in VasculitisSeerapani Gopaluni, David Jayne
Journal of Medical Case Reports|October 16, 2009
Superior vena cava obstruction presenting with epistaxis, haemoptysis and gastro-intestinal haemorrhage in two men receiving haemodialysis with central venous catheters: two case reportsSeerapani Gopaluni, Paul Warwicker
Clinical Kidney Journal|April 17, 2015
An unusual case of familial cystic kidney diseaseSeerapani Gopaluni, Matthew Gibson, Mobin Mohteshamzadeh
The Cochrane Database of Systematic Reviews|November 8, 2016
Interventions for chronic kidney disease-associated restless legs syndromeSeerapani Gopaluni, Mohamed Sherif, Naim A Ahmadouk
Nature Reviews. Rheumatology|November 4, 2018
Publisher Correction: B cell therapy in ANCA-associated vasculitis: current and emerging treatment optionsMark McClure, Seerapani Gopaluni, David Jayne, et al.
Nature Reviews. Rheumatology|August 16, 2018
B cell therapy in ANCA-associated vasculitis: current and emerging treatment optionsMark McClure, Seerapani Gopaluni, David Jayne, et al.
BMJ Case Reports|September 11, 2015
Focal segmental glomerulosclerosis in a patient with mantle cell lymphomaSumeet Hindocha, Seerapani Gopaluni, Graham P Collins, et al.
NDT Plus|June 29, 2017
An immunocompromised dialysis patient with skin and bone lesionsMiriam Jane Ball, Seerapani Gopaluni, Suresh Mathavakkannan, et al.
Rheumatology (Oxford, England)|June 17, 2021
Refractory ANCA-associated vasculitisSeerapani Gopaluni, Allyson C Egan, Marc Xipell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 13, 2018
Effect of Disease Activity at Three and Six Months After Diagnosis on Long-Term Outcomes in Antineutrophil Cytoplasmic Antibody-Associated VasculitisSeerapani Gopaluni, Oliver Flossmann, Mark A Little, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Current Treatment Options in Rheumatology|September 23, 2017
Clinical Trials in VasculitisSeerapani Gopaluni, David Jayne
Journal of Medical Case Reports|October 16, 2009
Superior vena cava obstruction presenting with epistaxis, haemoptysis and gastro-intestinal haemorrhage in two men receiving haemodialysis with central venous catheters: two case reportsSeerapani Gopaluni, Paul Warwicker
Clinical Kidney Journal|April 17, 2015
An unusual case of familial cystic kidney diseaseSeerapani Gopaluni, Matthew Gibson, Mobin Mohteshamzadeh
The Cochrane Database of Systematic Reviews|November 8, 2016
Interventions for chronic kidney disease-associated restless legs syndromeSeerapani Gopaluni, Mohamed Sherif, Naim A Ahmadouk
Nature Reviews. Rheumatology|November 4, 2018
Publisher Correction: B cell therapy in ANCA-associated vasculitis: current and emerging treatment optionsMark McClure, Seerapani Gopaluni, David Jayne, et al.
Nature Reviews. Rheumatology|August 16, 2018
B cell therapy in ANCA-associated vasculitis: current and emerging treatment optionsMark McClure, Seerapani Gopaluni, David Jayne, et al.
BMJ Case Reports|September 11, 2015
Focal segmental glomerulosclerosis in a patient with mantle cell lymphomaSumeet Hindocha, Seerapani Gopaluni, Graham P Collins, et al.
NDT Plus|June 29, 2017
An immunocompromised dialysis patient with skin and bone lesionsMiriam Jane Ball, Seerapani Gopaluni, Suresh Mathavakkannan, et al.
Rheumatology (Oxford, England)|June 17, 2021
Refractory ANCA-associated vasculitisSeerapani Gopaluni, Allyson C Egan, Marc Xipell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 13, 2018
Effect of Disease Activity at Three and Six Months After Diagnosis on Long-Term Outcomes in Antineutrophil Cytoplasmic Antibody-Associated VasculitisSeerapani Gopaluni, Oliver Flossmann, Mark A Little, et al.
Pageof 3